These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Study of serum hepcidin in hereditary hemolytic anemias. El Beshlawy A, Alaraby I, Abdel Kader MS, Ahmed DH, Abdelrahman HE. Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733 [Abstract] [Full Text] [Related]
4. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Am J Hematol; 2013 Feb; 88(2):97-101. PubMed ID: 23335357 [Abstract] [Full Text] [Related]
6. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Sasu BJ, Li H, Rose MJ, Arvedson TL, Doellgast G, Molineux G. Blood Cells Mol Dis; 2010 Oct 15; 45(3):238-45. PubMed ID: 20800515 [Abstract] [Full Text] [Related]
13. Hepcidin is a potential regulator of iron status in chronic kidney disease. Tsuchiya K, Nitta K. Ther Apher Dial; 2013 Feb 15; 17(1):1-8. PubMed ID: 23379486 [Abstract] [Full Text] [Related]
18. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G. Eur J Clin Invest; 2009 Oct 15; 39(10):883-90. PubMed ID: 19563467 [Abstract] [Full Text] [Related]